Victor Caprio – Managing Director
Victor brings significant Management and Public Health experience from the Private and Non-Profit Sectors. Victor also has substantial experience in Executive Management and providing sound guidance to new and emerging business professionals throughout Australia and Canada. Victor’s foresight for the Medicinal Cannabis industry is unparalleled and his Patient Management and Health Professional Liaison skills are what our Company prides itself on.
Dr. Mark Jeffrey – Pain Management Medical Practitioner
Dr. Jeffrey is a renowned Medical Practitioner and has substantial experience within the fields of General Practice, Anesthesia and Pain Management. He has a h2 passion for ensuring patients have adequate access to varied medicinal treatment options and promoting the reduction of use of opiate-based medicines as the perceived solution to neuropathic pain conditions. His continuous support for the prescription of medicinal cannabis to critical patients will continue into the future.
Jack Ma – Legal Counsel & International Strategist
Jack graduated from Bond University with dual Bachelor degrees in both Law, and International Relations. Upon completion of his studies, Jack was admitted to the Supreme Court of Queensland. Jack then furthered his studies at the Australian National University, obtaining a Master of Strategic Studies. Jack is currently leading an investment firm that has invested over $100 million dollars into Australia over the last 3 years. He is fluent in both English and Mandarin. Jack has a very deep understanding of geopolitical issues and is regarded as an expert in China and Asia Pacific Affairs.
Nicholas Quinn – Chief Operating Officer
Nicholas has a h2 background in Public Safety, Public Health and Environmental Science disciplines within both Private and Government Sectors. Nicholas has worked on critical projects with Australian Government Organisations, leading Organizational Change Initiatives, specifically in the Health and Environmental sectors, along with providing consultative services to Private Companies and Non-Governmental Organizations including the United Nations and the World Health Organization. He has a h2 passion for Public Health and assisting Health Professionals with ensuring that their Patient Network has access to all relevant treatment options, including that of Medicinal Cannabis.
Darren Bray- Chief Commercial Officer
As a Founding Member and Pioneer of one of the worlds largest CBD Companies based in the United States, Darren Bray brings a wealth of experience and strategic insight to the PharmaCann Team.
With a background in Business Management and Corporate Strategy, specific to the Agricultural and Cannabis Industries, his experience will assist in taking PharmaCann to the next level of its Global Program.
Adam Krauel – Chief Financial Officer:
Adam graduated from QUT with a Bachelor of Business majoring in Professional Accounting and is a Chartered Accountant with 15 years of experience in various industries. He brings a variety of skillsets to the business along with the traditional accounting role ranging from finance to government grants.
Geoff Schurer – Security and Risk Manager
Geoff has over 20 years in Security and Risk Management in both the Private and Government Sectors. His experience within these sectors is invaluable when it comes to meeting the regulatory and security parameters that is required for the Company. His reputation within the Security Fraternity and the Australian Security Industry Association will serve as an asset to our Company and to maintaining the strict security protocols set out in State and Federal Legislation.
Dr Sameer Tatavarty – Technical Advisor
Dr Sameer is currently serving as a Medical Registrar with a large Public Hospital. Dr Tatavarty holds a Bachelor of Medicine/Bachelor of Surgery from the University of Queensland, and a Bachelor if Biopharmaceutical Science from the University of Ottawa. With experience in regulatory affairs, pharmaceutical design and clinical trials, Dr Sameer will lead the PharmaCann Group with Clinical Trial initiatives and Biopharmaceutical design.
Steven Probert – Technical Advisor
The Chempro Group was established on the Gold Coast in 2002 when 5 large pharmacies were purchased with a turnover of more than 18 million dollars. Since then Steven has overseen the growth of the Chempro group to 80 + stores with its own direct distribution centre and marketing team. Chempro is set up for future growth and success with 10 more stores planned for 2018.
Steven is a hands on CEO managing many day to day operations of the company, which has a combined turnover of more than 300 million dollars today.